我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

粥样斑块发生发展过程中炎症和新生内膜血管之间的关系(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2006年第6期
页码:
636-639,642
栏目:
基础研究
出版日期:
2006-12-25

文章信息/Info

Title:
Relation between inflammation and intimal neovascularization in the progress of atheromatous plaque
作者:
宋涛冯莉萍夏豪江洪
武汉大学人民医院心血管内科,湖北 武汉,430060
Author(s):
SONG Tao FENG Li-ping XIA Hao JIANG Hong
Department of Cardiology, Wuhan University Renmin Hospital, Wuhan, Hubei 430060, China
关键词:
内膜新生血管粥样斑块炎症血管生成抑制剂血管生成促进剂
Keywords:
intimal neovascularization atheromatous plaque inflammation angiogenesis inhibitor angiogenesis accelerator
分类号:
R363;R541.4
DOI:
-
文献标识码:
A
摘要:
目的 为研究在控制炎症水平的情况下内膜新生血管在动脉粥样斑块发生、发展中所起到的具体作用。 方法 高脂饮食8周造成大鼠动脉粥样硬化(AS)模型,然后使用阿司匹林抑制AS大鼠的基础炎症水平,分别给予内皮抑素和血管内皮生长因子165(VEGF165)两种不同方法处理大鼠,8周后比较血脂、胸主动脉形态学、以及检测CD31表达水平以计算内膜新生血管的数量。 结果 模型组的血脂水平高于空白对照组(P<0.05);粥样斑块内部的新生血管数量VEGF165+阿司匹林组>单纯模型对照组>阿司匹林组>内皮抑素+阿司匹林组>空白对照组(P<0.05);阿司匹林组、内皮抑素+阿司匹林组和VEGF165+阿司匹林组的内膜面积/中膜面积的比值(IA/MA)差异无显著性,但高于单纯模型对照组(P<0.05)。 结论 在用阿司匹林抑制AS模型大鼠基础炎症的情况下,VEGF165和内皮抑素对血管内膜生成的影响无显著差异。
Abstract:
AIM To investigate the role of intimal neovascularization in atheromatous plaque under the control of inflammation. METHODS To establish the model of Atherosclerosis, employing asprin to control basic inflammation level. The rats were treated with endostatin and VEGF165 separately. 8 weeks later, compared the serum cholesterol, morphology of aorta and count the amount of intimal neovascularization by measure the expression of CD31. RESULTS The serum cholesterol level of model group was higher than blank comparison(P<0.05); the amount of intimal neovascularization: VEGF165group> model control group>aspirin group> endostatin group> blank comparison group(P<0.05); the IA/MA ratio was no different in all groups(P<0.05) . CONCLUSION when asprin was used to control the inflammation of AS model of rats,the VEGF165 and endostatin had no significant effect on the intima.

参考文献/References

[1] Chen YX, Nakashima Y, Tanaka K, et al. Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimals of human coronary arteries [J]. Arterioscler Thromb Vasc Biol, 1999, 19(1): 131-139.

[2] Moulton KS, Heller E, Konerding MA, et al. Angiogenesis inhibitors endostatin or TNP470 reduce intimal neovasculatization and plaque growth in apolipoprotein Edeficient mice [J]. Circulation, 1999, 99(13): 1726-1732.

[3] 温进坤,韩梅,杜玮南,等. 一种快速建立大鼠动脉粥样硬化模型的实验方法[J].中国老年学杂志,2001,21(1):50-52.

[4] 沈丽,卢维晟,姚俊宇,等. 不同方法建立动脉粥样硬化大鼠模型的比较[J].心脏杂志,2005,17(1):18-20.

[5] 陈仕林,张宝仁,梅举,等. 血管形成素1基因对兔缺血心肌中血管的新生作用[J].中华医学杂志,2003,83(8):637-640.

[6] Celletti FL, Hilfiker PR, Ghafouri P, et al. Effect of human recombinant vasculat endothelial growth factor 165 on progression of atherosclerotic plaque [J]. J Am Coll Cardiol,2001, 37(8):2126-2130.

[7] Mofidi R, Crotty TB, McCarthy P, et al. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease [J]. Br J Surg, 2001,88(7):945-950.

[8] Fleiner M, Kummer M, Mirlacher M, et al. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis [J]. Circulation,2004,110(18):2843-2850.

[9] Moulton KS, Vakili K, Zurakowski D, et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis [J]. Proc Natl Acad Sci USA, 2003, 100(8):4736-4741.

[10]孙璐,韦立新,石怀银,等. 冠状动脉粥样硬化斑块内血管新生与斑块稳定的关系[J].中华病理学杂志,2003,32(5):427-431.

备注/Memo

备注/Memo:
收稿日期:2005-11-28.通讯作者:夏豪,副教授,主要从事介入心脏病学研究 Tel:(027)88041911-2214 作者简介:宋涛,硕士 Tel:(027)88328605 Email:songtao_099@163.com
更新日期/Last Update: